{"abstract":"The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Summary Information section of this notice to the International Medica Foundation located in Shoreview, Minnesota, U.S.A.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2017/06/05/2017-11491.html","cfr_references":[],"citation":"82 FR 25804","comment_url":null,"comments_close_on":"2017-06-20","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Institute of Allergy and Infectious Diseases' Technology Transfer and Intellectual Property Office on or before June 20, 2017 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2017-11491","effective_on":null,"end_page":25805,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2017/06/05/2017-11491.xml","html_url":"https://www.federalregister.gov/documents/2017/06/05/2017-11491/prospective-grant-of-exclusive-patent-license-production-of-attenuated-west-nile-virus-vaccines","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2017-11491?publication_date=2017-06-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2017-06-05/2017-11491/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":1047,"last_updated":"2026-06-24 22:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2017-06-05/pdf/2017-11491.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2017-11491.pdf?1496407530","publication_date":"2017-06-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2017/06/05/2017-11491.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T00:08:54Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":25804,"subtype":null,"title":"Prospective Grant of Exclusive Patent License: Production of Attenuated West Nile Virus Vaccines","toc_doc":"Production of Attenuated West Nile Virus Vaccines","toc_subject":"Prospective Grants of Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":82}